Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
CHO clones HEK 293 Vero MDCK Fibroblasts LONG R3 IGF-I is available in two formats, both stable at 2-8C
[3] Popularity is expected to grow, with global sales estimated to climb to $139 billion by 2030
View archived Retatrutide 10mg COA Product Details Compound: Retatrutide Quantity: 10mg per vial Form: Lyophilised powder Purity: Research grade, COA verification available Packaging: Sterile sealed glass vial Use: Laboratory research use only Research & Handling Supplied strictly for laboratory research use only Suitable for controlled experimental environments Handled using standard laboratory safety procedures Review COA and batch data before use Not for human consumption or medical application Storage Guidance Store in a cool, dry place Keep away from direct sunlight and heat Refrigeration is recommended after reconstitution Avoid repeated freeze and thaw cycles Follow appropriate laboratory storage protocols UK Delivery Information UK dispatch on available stock Royal Mail Tracked24 available Free UK shipping on orders over 50 Discreet and secure packaging Tracking details provided once scanned into the Royal Mail network Why Choose Astra Labs
California Department of Health Care Services spokesperson Tessa Outhyse said in an email that the official advice to try those other approaches now is not meant to dismiss any past efforts, but to encourage Medi-Cal members to take a renewed, proactive, and medically supported approach with their healthcare provider that may appropriately include these additional options. But that may be unrealistic, said Kurt Hong, founding director of the Center for Clinical Nutrition at Keck School of Medicine of the University of Southern California
The FDA resolved the semaglutide and tirzepatide shortages in 2025, ending the broad shortage-based pathway that powered large-scale compounding, and in April 2026 proposed excluding these drugs from the 503B bulks list, with a comment period through June 29, 2026
